Jun 5, 2026 08:00AM
Jun 3, 2026 06:53AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM
May 13, 2026 08:02AM UroGen reports 64.5% three-year response rate for ZUSDURI bladder cancer drug
May 13, 2026 08:00AM
May 11, 2026 07:12AM
May 6, 2026 08:00AM
Mar 30, 2026 08:05AM
Mar 30, 2026 08:00AM
Mar 6, 2026 04:10PM
Mar 2, 2026 08:04AM UroGen launches ZUSDURI as revenue rises 21% in 2025
Mar 2, 2026 08:00AM
Feb 27, 2026 08:30AM
Feb 24, 2026 04:05PM
Feb 23, 2026 08:00AM
Feb 4, 2026 08:00AM
Jan 5, 2026 08:00AM
Dec 22, 2025 07:06AM Piper Sandler Highlights Top Picks in the Biopharma 2026 Preview Note
Dec 5, 2025 08:00AM
Nov 6, 2025 08:00AM
Nov 6, 2025 07:58AM
Nov 6, 2025 07:58AM
Nov 4, 2025 08:00AM
Oct 30, 2025 08:00AM
Oct 27, 2025 08:00AM Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI™ Effective January 1, 2026
Oct 24, 2025 08:29AM
Oct 2, 2025 08:02AM
Oct 2, 2025 08:00AM
Sep 8, 2025 08:00AM
Aug 21, 2025 08:00AM
Aug 19, 2025 06:18AM
Aug 7, 2025 08:00AM UroGen Pharma Expands Commercial Portfolio with Launch of ZUSDURI™ and Reports Second Quarter 2025 Financial Results
Aug 5, 2025 08:00AM
Aug 5, 2025 08:00AM
Jul 29, 2025 08:00AM
Jul 28, 2025 08:00AM
Jul 28, 2025 08:00AM
Jul 21, 2025 08:05AM
Jul 21, 2025 08:00AM UroGen Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI™ in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive
Jul 8, 2025 06:50AM
Jul 7, 2025 08:04AM
Jul 7, 2025 08:00AM
Jul 6, 2025 10:00AM
Jul 1, 2025 10:00AM
Jun 28, 2025 10:00AM
Jun 23, 2025 11:07AM INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of UroGen Pharma Ltd. - URGN
Jun 18, 2025 11:21AM

323,580 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All